Keybanc analyst Aleksey Yefremov maintains PPG Indus (NYSE:PPG) with a Overweight and raises the price target from $125 to $144.
SVB Leerink Maintains Outperform on Avidity Biosciences, Raises Price Target to $53
SVB Leerink analyst Joseph Schwartz maintains Avidity Biosciences (NASDAQ:RNA) with a Outperform and raises the price target from $36 to $53.